Related Experiment Video

Updated: Aug 5, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Therapeutic Cancer Vaccines: Mechanisms, Clinical Progress, and Future Directions

Kendra Wilson1, Jesus Salvador Flores Banda2, Sanjana Bukkapatnam3

  • 1Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Texas at Tyler School of Medicine, 11937 US-271, Tyler, TX 75708, USA.

Vaccines
|July 27, 2026
PubMed

Insights

Therapeutic cancer vaccines show promise in immunotherapy but have variable efficacy. Combining these vaccines with other treatments, like immune checkpoint inhibitors, is key for future success.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines aim to harness the immune system against cancer.
  • Clinical efficacy of current vaccine platforms is inconsistent.
  • Understanding factors influencing vaccine response is crucial.

Purpose of the Study:

  • To review clinical trials of major therapeutic cancer vaccine modalities.
  • To evaluate safety, immunogenicity, and clinical outcomes.
  • To identify factors affecting efficacy across diverse tumor types.

Main Methods:

  • Systematic review of completed clinical trials.
  • Analysis of peptide-based, nucleic acid--based, dendritic cell, whole cell, and vector-based vaccines.
  • Focus on safety, immunogenicity, and clinical outcomes.

Main Results:

  • Therapeutic cancer vaccines generally have a favorable safety profile.
  • Monotherapy clinical efficacy has been limited.
  • Outcomes vary by vaccine platform, tumor type, antigen choice, and tumor microenvironment (TME).

Conclusions:

  • Advances in antigen design and combination strategies are improving vaccine roles in oncology.
  • Optimizing integration with standard treatments, especially immune checkpoint inhibitors, is essential for future progress.
  • Therapeutic cancer vaccines hold potential but require strategic implementation.
Keywords:
allogeneic tumor cell vaccinesautologous tumor cell vaccinesbacterial-based vaccinesdendritic cell vaccinesnucleic acid vaccinespeptide-based vaccinestherapeutic cancer vaccinesviral vector-based vaccines

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...